Perseus Proteomics Inc. reported impairment loss for the first quarter of the fiscal year 2023. For the quarter, the company booked impairment loss of JPY 129,845,000 for its non-current assets in accordance with the Accounting Standard for Impairment of Fixed Assets.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
325 JPY | +5.18% | -0.61% | -47.41% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-47.41% | 24.31M | |
-2.29% | 89.38B | |
-3.95% | 37.92B | |
-13.07% | 32.04B | |
+63.05% | 26.03B | |
-22.14% | 14.14B | |
-7.96% | 12.88B | |
-9.33% | 11.77B | |
-46.33% | 10.85B | |
+5.77% | 8.92B |
- Stock Market
- Equities
- 4882 Stock
- News Perseus Proteomics Inc.
- Perseus Proteomics Inc. Reports Impairment Loss for the First Quarter of the Fiscal Year 2023